Search results for "nephrology"

showing 10 items of 673 documents

Characterization of human infiltrating and circulating gamma-delta T cells in prostate cancer

2019

Purpose The aim of our study was to prospectively evaluate the distribution of gamma-delta (γδ)1 and γδ2 T cells and their phenotypes in peripheral blood and prostate samples of patients diagnosed with or without prostate cancer (PCa) at prostate biopsy. Materials and methods A consecutive series of 43 outpatients underwent trans-rectal echo-guided prostate biopsy for suspected PCa. Flow cytometry analysis was used to identify and characterize the γδ T cells populations in peripheral blood and tissue samples. Patients were stratified according to the presence or not of PCa, and its International Society of Urological Pathology (ISUP) grade (1 vs. ≥2). Results The distribution of γδ T cells …

MalePathologymedicine.medical_specialtyProstate biopsyT-Lymphocyte subsetUrological OncologyBiopsyUrology030232 urology & nephrologylcsh:RC870-923Flow cytometry03 medical and health sciencesProstate cancerLymphocytes Tumor-Infiltrating0302 clinical medicineProstateBiopsymedicineHumansProspective StudiesIntraepithelial LymphocytesAgedNeoplasm gradingmedicine.diagnostic_testbusiness.industryCancerMiddle AgedNeoplastic Cells Circulatinglcsh:Diseases of the genitourinary system. Urologymedicine.diseasePhenotypeImmunologic surveillanceImmunosurveillancemedicine.anatomical_structure030220 oncology & carcinogenesisOriginal ArticleProstatic neoplasmsProstatic neoplasmbusinessT-Lymphocyte subsetsInvestigative and Clinical Urology
researchProduct

Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients

2016

International audience; Anemia management, based on erythropoiesis stimulating agents (ESA) and iron supplementation, has become an increasingly challenging problem in hemodialysis patients. Maintaining hemodialysis patients within narrow hemoglobin targets, preventing cycling outside target, and reducing ESA dosing to prevent adverse outcomes requires considerable attention from caregivers. Anticipation of the long-term response (i.e. at 3 months) to the ESA/iron therapy would be of fundamental importance for planning a successful treatment strategy. To this end, we developed a predictive model designed to support decision-making regarding anemia management in hemodialysis (HD) patients tr…

MalePediatricsBlood transfusionDarbepoetin alfaPhysiologymedicine.medical_treatment030232 urology & nephrologylcsh:Medicine030204 cardiovascular system & hematologyFerric CompoundsBiochemistryGlucaric AcidHemoglobinsMathematical and Statistical Techniques0302 clinical medicineMedicine and Health SciencesDarbepoetin alfaErythropoiesislcsh:ScienceFerric Oxide SaccharatedMultidisciplinaryPharmaceuticsDisease ManagementAnemia[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHematologyMiddle Aged3. Good healthNephrologyInjections IntravenousPhysical SciencesFemaleHemodialysisStatistics (Mathematics)Research Articlemedicine.drugComputer and Information Sciencesmedicine.medical_specialtyAnemiaResearch and Analysis Methods03 medical and health sciencesDose Prediction MethodsRenal DialysisArtificial IntelligenceMedical DialysismedicineHumansHemoglobinDosingStatistical MethodsIron Deficiency AnemiaIntensive care medicineArtificial Neural NetworksAgedRetrospective StudiesComputational NeuroscienceModels Statisticalbusiness.industrylcsh:RBiology and Life SciencesComputational BiologyProteinsRetrospective cohort studymedicine.diseaseIron-deficiency anemiaHematinicsKidney Failure ChronicCognitive Sciencelcsh:QNeural Networks ComputerHemoglobinPhysiological ProcessesbusinessMathematicsNeuroscienceForecasting
researchProduct

Nutritional Status of Maintenance Dialysis Patients: Low Lean Body Mass Index and Obesity Are Common, Protein-Energy Wasting Is Uncommon.

2016

Background and Aims Maintenance dialysis patients are at increased risk of abnormal nutritional status due to numerous causative factors, both nutritional and non-nutritional. The present study assessed the current prevalence of protein-energy wasting, low lean body mass index and obesity in maintenance dialysis patients, and compared different methods of nutritional assessment. Methods In a cross-sectional study conducted in 2014 at Roskilde Hospital, Denmark, we performed anthropometry (body weight, skinfolds, mid-arm, waist, and hip circumferences), and determined plasma albumin and normalized protein catabolic rate in order to assess the prevalence of protein-energy wasting, low lean bo…

MalePediatricsProtein–energy malnutritionPhysiologyCross-sectional study030232 urology & nephrologySocial Scienceslcsh:Medicine030204 cardiovascular system & hematologyBiochemistryBody Mass IndexFats0302 clinical medicinePrevalenceMedicine and Health SciencesYoung adultlcsh:ScienceWastingAged 80 and overMultidisciplinaryAnthropometryMiddle AgedLipidsPhysiological ParametersNephrologyPhysical SciencesBody CompositionEngineering and TechnologyFemalePhysical AnthropologyWaist Circumferencemedicine.symptomResearch ArticleAdultmedicine.medical_specialtyMaterials ScienceNutritional StatusFuelsProtein-Energy MalnutritionYoung Adult03 medical and health sciencesRenal DialysisAlbuminsInternal medicineMedical DialysismedicineHumansObesityMaterials by AttributeAgedNutritionbusiness.industryBody Weightlcsh:RBiology and Life SciencesProteinsAnthropometrymedicine.diseaseObesityEnergy and PowerCross-Sectional StudiesEndocrinologyAnthropologyLean body massKidney Failure Chroniclcsh:QbusinessBody mass indexPLoS ONE
researchProduct

Congenital Solitary Kidney in Children: Size Matters

2016

We assessed renal function outcome in children with congenital solitary kidney and evaluated prognostic risk factors.We retrospectively studied the clinical charts of 210 children presenting with congenital solitary kidney at 2 pediatric nephrology and 5 pediatric units between January 2009 and October 2012. Children 0 to 18 years old with a congenital solitary kidney confirmed by scintigraphy were enrolled. Of the patients 146 were suitable for analysis. Median followup was 4.6 years. Primary outcome was decreased estimated glomerular filtration rate, and secondary outcome was occurrence of proteinuria and/or systemic hypertension. Primary outcome-free survival analysis was performed, incl…

MalePediatricsmedicine.medical_specialtyPathologyUrology030232 urology & nephrologyRenal functionKidneyScintigraphySolitary Kidney03 medical and health sciences0302 clinical medicinePrimary outcomeRisk Factors030225 pediatricsmedicineHumansPediatric nephrologySignificant riskSurvival analysisRetrospective StudiesUltrasonographyProteinuriamedicine.diagnostic_testbusiness.industryInfantOrgan SizeCongenital Solitary KidneyPrognosisChild PreschoolFemalemedicine.symptombusinessFollow-Up StudiesGlomerular Filtration RateJournal of Urology
researchProduct

Free Bipedicled Radial Forearm and Posterior Interosseous Artery Perforator Flap Phalloplasty

2019

Abstract Introduction The free radial forearm (FRFA) flap is universally still considered as the gold standard technique in penile reconstruction. Typically, a considerably large flap is required, often involving almost the entire circumference of the forearm. Partial necrosis may occur at the distal-most (dorsoradial) part of the flap as a result of insufficient perfusion. Aim To describe a new technique using the posterior interosseous artery (PIOA) to supercharge FRFA phalloplasty. Methods In a 12-month period, all patients having FRFA flap phalloplasty were enrolled. Perioperative, after complete flap dissection, an indocyanine green perfusion scan was performed. In case of insufficient…

MalePhalloplastymedicine.medical_specialtyUrologyEndocrinology Diabetes and MetabolismFistula030232 urology & nephrologySettore MED/19 - Chirurgia PlasticaPerfusion scanningAnastomosisPenile Reconstruction03 medical and health sciencesPostoperative Complications0302 clinical medicineEndocrinologyUrethraForearmmedicine.arterymedicineSex Reassignment SurgeryHumansPenile Reconstruction; Phalloplasty; Sex Reassignment Surgery; Transmen030219 obstetrics & reproductive medicinebusiness.industryArteriesmedicine.diseaseSurgeryPosterior interosseous arteryForearmPsychiatry and Mental healthStenosisPosterior interosseous nervemedicine.anatomical_structureReproductive MedicineTransmenFemalePhalloplastybusinessPerforator FlapPenis
researchProduct

Adverse metabolic response to regular exercise: Is it a rare or common occurrence?

2012

Background. Individuals differ in the response to regular exercise. Whether there are people who experience adverse changes in cardiovascular and diabetes risk factors has never been addressed. Methodology/Principal Findings. An adverse response is defined as an exercise-induced change that worsens a risk factor beyond measurement error and expected day-to-day variation. Sixty subjects were measured three times over a period of three weeks, and variation in resting systolic blood pressure (SBP) and in fasting plasma HDL-cholesterol (HDL-C), triglycerides (TG), and insulin (FI) was quantified. The technical error (TE) defined as the within-subject standard deviation derived from these measur…

MalePhysical fitnesslcsh:MedicineBlood Pressure030204 cardiovascular system & hematologyCardiovascularBiochemistry0302 clinical medicineRisk FactorsMedicineInsulinlcsh:ScienceMultidisciplinaryCongenital Heart DiseaseFastingMiddle Agedadverse response3. Good healthExercise TherapyNephrologyCardiovascular DiseasesCohortHypertensionMedicineFemalePublic HealthExercise prescriptionResearch ArticleAdultmedicine.medical_specialtyDiabetes riskExercise training03 medical and health sciencesInternal medicineDiabetes mellitusDiabetes MellitusHumansRisk factorSports and Exercise MedicineBiologyExerciseTriglyceridesAgedbusiness.industrylcsh:RCholesterol HDL030229 sport sciencesmedicine.diseaseAtherosclerosisEpidemiologic StudiesEndocrinologyBlood pressureMetabolismMetabolic DisordersBasal metabolic ratelcsh:QPhysiotherapy and RehabilitationPreventive MedicineBasal Metabolismbusiness
researchProduct

Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.

2017

Background Non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation or precursor of metabolic syndrome, may increase nephrolithiasis, a renal manifestation of insulin resistance, but the prospective association between NAFLD and incident nephrolithiasis has not been evaluated. We examined the association of NAFLD with the development of nephrolithiasis in a large cohort of Korean men and women. Methods We performed a cohort study of 208,578 Korean adults who underwent a health checkup examination between January 2002 and December 2014 and were followed-up annually or biennially through December 2014. NAFLD was defined as the presence of fatty liver in the absence of excessive alco…

MalePhysiology030232 urology & nephrologylcsh:MedicineBlood PressureGastroenterologyVascular MedicineBody Mass IndexCohort Studies0302 clinical medicineEndocrinologyNon-alcoholic Fatty Liver DiseaseMedicine and Health Scienceslcsh:ScienceMultidisciplinaryAlcohol ConsumptionIncidence (epidemiology)Liver DiseasesHazard ratioFatty liverMiddle AgedChemistryPhysiological ParametersResearch DesignHypertensionPhysical Sciences030211 gastroenterology & hepatologyFemaleCohort studyResearch ArticleAdultmedicine.medical_specialtyEndocrine DisordersGastroenterology and HepatologyNephrolithiasisResearch and Analysis Methods03 medical and health sciencesInsulin resistanceInternal medicineDiabetes mellitusmedicineDiabetes MellitusHumansNutritionEndocrine Physiologybusiness.industrylcsh:RBody WeightChemical Compoundsnutritional and metabolic diseasesBiology and Life Sciencesmedicine.diseasedigestive system diseasesDietUric AcidFatty LiverMetabolic Disorderslcsh:QMetabolic syndromeInsulin ResistancebusinessBody mass indexAcidsPloS one
researchProduct

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outs…

2021

Background ADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous treatment for intensive care patients with liver failure. Data related to the applicability and safety as discontinuous treatment outside of ICU is not available. Aim Evaluation of ADVOS as discontinuous treatment for patients with ACLF outside intensive care unit and comparison with a matched historic cohort. Methods and results In this retrospective study, 26 patients with ACLF and the indication for renal replacement therapy related to HRS-AK…

MalePhysiologymedicine.medical_treatmentLiver transplantationToxicologyPathology and Laboratory MedicineSeverity of Illness IndexBiochemistrylaw.inventionBlood Urea Nitrogen0302 clinical medicinelawLiver Cirrhosis AlcoholicMedicine and Health SciencesMedicineBileMultidisciplinaryLiver DiseasesQRMiddle AgedIntensive care unitBody FluidsRenal Replacement TherapyLiverCirrhosisNephrologyCreatinineMedicine030211 gastroenterology & hepatologyFemaleHemodialysisAnatomyDetoxificationResearch Articlemedicine.medical_specialtyCritical CareScienceSurgical and Invasive Medical ProceduresGastroenterology and Hepatology03 medical and health sciencesDigestive System ProceduresRenal DialysisIntensive careInternal medicineAlbuminsMedical DialysisHumansRenal replacement therapyDialysisRetrospective StudiesTransplantationbusiness.industryAcute-On-Chronic Liver FailureBiology and Life SciencesProteins030208 emergency & critical care medicineRetrospective cohort studyBilirubinOrgan TransplantationSurvival AnalysisLiver TransplantationPatient ComplianceLiver functionbusinessBiomarkersPLoS ONE
researchProduct

Genomic and metabolomic profile associated to microalbuminuria.

2013

To identify factors related with the risk to develop microalbuminuria using combined genomic and metabolomic values from a general population study. One thousand five hundred and two subjects, Caucasian, more than 18 years, representative of the general population, were included. Blood pressure measurement and albumin/creatinine ratio were measured in a urine sample. Using SNPlex, 1251 SNPs potentially associated to urinary albumin excretion (UAE) were analyzed. Serum metabolomic profile was assessed by 1H NMR spectra using a Brucker Advance DRX 600 spectrometer. From the total population, 1217 (mean age 54 ± 19, 50.6% men, ACR>30 mg/g in 81 subjects) with high genotyping call rate were ana…

MaleProteomicsVesicular Transport ProteinsPhysiologyBlood PressureBiochemistryVascular Medicinechemistry.chemical_compoundEndocrinologyGenotypeMedicine and Health SciencesGeneticseducation.field_of_studyMultidisciplinarySpectrometric Identification of ProteinsQRGenomicsMiddle AgedMitochondriaType 2 DiabetesNephrologyHypertensionMetabolomePopulation studyMedicineFemaleMetabolic Pathwaysmedicine.symptomResearch ArticleAdultGenotypeSciencePopulationCardiologySingle-nucleotide polymorphismNerve Tissue ProteinsBiologyPeptidyl-Dipeptidase APolymorphism Single NucleotideGenomic MedicinemedicineGeneticsDiabetes MellitusAlbuminuriaHumansMetabolomicsGenetic TestingeducationGenotypingAdaptor Proteins Signal TransducingAgedClinical GeneticsDiabetic EndocrinologyCreatinineEvolutionary BiologyBiology and Life Sciencesmedicine.diseaseMetabolismchemistryMetabolic DisordersAlbuminuriaGenetic PolymorphismMicroalbuminuriaPopulation GeneticsPLoS ONE
researchProduct

Radium-223 in mCPRC patients: a large real-life Italian multicenter study

2020

Background Radium-223 is a targeted alpha-particles therapy approved for the treatment of mCRPC patients with symptomatic bone metastases. To our knowledge we account for the largest cohort of mCRPC patients subjected to Radium-223 treatment in our country. We aim to describe in a real-life setting the largest cohort of mCRPC patients treated with Radium-223 ever taken into consideration. Methods 430 consecutive mCRPC patients were enrolled. Clinical data have been collected at baseline and at the end of the Radium-223 treatment. Furthermore, the overall survival(OS) of our population has been provided. Results 157 patients (36.5%) were still alive at the time of data analysis. A mean numbe…

MaleRadium-223radium-223; mCRPC; prostate cancer; target alpha therapyPediatricsmedicine.medical_specialtyradium-223UrologyPopulationBone NeoplasmsContext (language use)Quality of lifemedicineHumanseducationeducation.field_of_studybusiness.industrymCRPCprostate cancerProstatic Neoplasms Castration-ResistantRegimenSafety profileTreatment OutcomeItalyMulticenter studyNephrologyCohortQuality of LifeSettore SECS-S/01businesstarget alpha therapyRadiummedicine.drugMinerva Urology and Nephrology
researchProduct